Who owns VOR BIOPHARMA INC?
- Ticker: VOR
- CUSIP Number: 929033207
Tip: Access positions for across all investors
Analyze quarterly positions in Vor Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vor Biopharma stock
Who bought or sold VOR BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Fcpm Iii Services B.v. | 3.6M | $47M | 853% | Dec 2025 |
|
| Frazier Life Sciences Management | 2.5M | $33M | 100% | Dec 2025 |
|
| RA Capital Management | 2.0M | $97M | 100% | Sep 2025 |
|
| VR Adviser | 1.9M | $25M | 289% | Dec 2025 |
|
| Paradigm Biocapital Advisors | 1.8M | $23M | 100% | Dec 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.4M | $18M | 100% | Dec 2025 |
|
| Susquehanna International | 1.4M | $18M | -76% | Dec 2025 |
|
| Caligan Partners | 925k | $10M | 100% | Dec 2025 |
|
| Vanguard Group | 770k | $10M | 632% | Dec 2025 |
|
| BlackRock | 466k | $6.1M | 1248% | Dec 2025 |
|
| Sphera Funds Management | 410k | $5.4M | 100% | Dec 2025 |
|
| Laurion Capital Management | 317k | $4.1M | 100% | Dec 2025 |
|
| UBS Group | 292k | $3.8M | 285% | Dec 2025 |
|
| FMR | 237k | $12M | 100% | Sep 2025 |
|
| Findell Capital Management | 231k | $3.0M | 100% | Dec 2025 |
|
| Geode Capital Management | 186k | $2.4M | 578% | Dec 2025 |
|
| Ameriprise Financial | 163k | $2.1M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 146k | $1.9M | 823% | Dec 2025 |
|
| Jane Street | 105k | $1.4M | 176% | Dec 2025 |
|
| Logos Global Management | 100k | $1.3M | 100% | Dec 2025 |
|
| State Street Corporation | 91k | $1.2M | 906% | Dec 2025 |
|
| Belvedere Trading | 58k | $37k | -51% | Dec 2025 |
|
| Johnson & Johnson | 54k | $703k | 0% | Dec 2025 |
|
| Northern Trust | 39k | $509k | 100% | Dec 2025 |
|
| Engineers Gate Manager | 28k | $369k | 100% | Dec 2025 |
|
| Quadrature Capital | 27k | $350k | 100% | Dec 2025 |
|
| Hudson Bay Capital Management | 26k | $345k | 24% | Dec 2025 |
|
| Sarissa Capital Management | 25k | $332k | 0% | Dec 2025 |
|
| Citadel Advisors | 25k | $1.2M | 100% | Sep 2025 |
|
| Millennium Management | 25k | $1.2M | 100% | Sep 2025 |
|
| Bollard | 24k | $314k | 764% | Dec 2025 |
|
| OMERS Administration Corporation | 21k | $271k | 100% | Dec 2025 |
|
| Squarepoint Ops | 19k | $241k | 290% | Dec 2025 |
|
| XTX Topco | 18k | $229k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 11k | $141k | 100% | Dec 2025 |
|
| None | 11k | $141k | 100% | Dec 2025 |
|
| Susquehanna Portfolio Strategies | 10k | $134k | 100% | Dec 2025 |
|
| Chung Wu Investment Group | 8.3k | $109k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 6.3k | $305k | 100% | Sep 2025 |
|
| China Universal Asset Management | 2.7k | $36k | 100% | Dec 2025 |
|
| Tower Research Capital | 1.7k | $23k | 43125% | Dec 2025 |
|
| Barclays | 1.4k | $18k | 100% | Dec 2025 |
|
| Mirae Asset Global Investments | 819.00 | $11k | 100% | Dec 2025 |
|
| Gf Fund Management | 330.00 | $4.3k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 291.00 | $3.8k | -95% | Dec 2025 |
|
| Jpmorgan Chase & Co | 78.00 | $3.8k | 100% | Sep 2025 |
|
| MAI Wealth Advisors | 40.00 | $524.000000 | 0% | Dec 2025 |
|
| Hanson McClain Advisors | 3.00 | $39.999900 | 0% | Dec 2025 |
|
| SBI Securities | 3.00 | $39.000000 | 0% | Dec 2025 |
|
| Royal Bank of Canada | 2.00 | $0 | 100% | Sep 2025 |
|
| Wells Fargo & Company | 1.00 | $13.000000 | 0% | Dec 2025 |
|
Who sold out of Vor Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Shay Capital | Sep 2025 | 720k | $35M |
| Ariose Capital Management | Sep 2025 | 110k | $5.4M |
| Tang Capital Management | Sep 2025 | 50k | $2.4M |
| Woodline Partners | Sep 2025 | 27k | $1.3M |
| Polymer Capital Management | Sep 2025 | 21k | $1.0M |
| Renaissance Technologies | Sep 2025 | 15k | $711k |
| Virtu Financial | Sep 2025 | 8.1k | $395k |
| Scientech Research | Sep 2025 | 6.1k | $297k |
| Trustees of Columbia University in the City of New York | Sep 2025 | 4.6k | $224k |
| Caitong International Asset Management | Sep 2025 | 110.00 | $5.4k |